Improving treatment adherence in your patients with schizophrenia: the STAY initiative.
about
Critical appraisal of 3-monthly paliperidone depot injections in the treatment of schizophreniaRates and predictors of adherence to psychotropic medications in children with autism spectrum disorders.Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics.Adherence with general healthcare among internal medicine outpatients with mental health treatment histories.[Risk factors for treatment adherence in patients with schizophrenia: case-control study].Paliperidone palmitate in non-acute patients with schizophrenia previously unsuccessfully treated with risperidone long-acting therapy or frequently used conventional depot antipsychotics.Pharmacy switch of antipsychotic medications: patient's perspective.Psychiatrists' awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa.Current approaches to treatments for schizophrenia spectrum disorders, part II: psychosocial interventions and patient-focused perspectives in psychiatric care.Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional studyClinical benefits and impact of early use of long-acting injectable antipsychotics for schizophrenia.Medication adherence in patients with schizophrenia.Universal antiretroviral regimens: thinking beyond one-pill-once-a-day.Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People's Republic of China.Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies.Psychiatrists' awareness of partial- and non-adherence to antipsychotic medication in schizophrenia: results from the Australian ADHES survey.
P2860
Q26745792-6BE7B90F-1A82-4D51-80E0-26220B26C4D0Q34424843-8B1516AB-E437-4E3D-A01B-6924E4CEE45EQ35224289-2761440B-4DE0-45B3-A6DF-C8BF8A097838Q35570854-3AAA5F6B-7760-423B-AF3E-B8CBD48F71CBQ35793302-22072672-E94D-44F1-9D5C-56C9894925C2Q35882300-BD121A20-2FE3-4D74-9A62-233A76B1AF2DQ36093400-B4E3FB3F-B0FD-4853-8919-6798C8B060F9Q36587739-5BF0BAE3-FA77-4C6E-A684-AFD102396B89Q37221010-57CFC577-6D7D-4057-8D76-8CAFA7F74F49Q37547469-E9487B1C-8D9C-48A2-B851-1303B9847289Q38592404-39276816-2B10-4D72-93C3-E444858CB229Q38808583-62B926CC-D57D-4D15-9018-14A9280AD775Q39215169-67A3F588-0E23-4C83-8A0D-AEE8272C5E81Q40022563-BF55DA31-019E-4D07-B22A-EAC66A8F608CQ40906666-59F9B995-1B0C-42CF-8F20-607D9DADA410Q41201128-9185F644-A0C0-4AED-A93F-2C397610306C
P2860
Improving treatment adherence in your patients with schizophrenia: the STAY initiative.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Improving treatment adherence in your patients with schizophrenia: the STAY initiative.
@en
type
label
Improving treatment adherence in your patients with schizophrenia: the STAY initiative.
@en
prefLabel
Improving treatment adherence in your patients with schizophrenia: the STAY initiative.
@en
P2093
P2860
P50
P1476
Improving treatment adherence in your patients with schizophrenia: the STAY initiative.
@en
P2093
Dieter Naber
Fernando Cañas
Georgios Papageorgiou
Jean Michel Azorin
José M Olivares
Koksal Alptekin
Peter M Haddad
Robin Emsley
Vincent Dubois
P2860
P304
P356
10.1007/S40261-012-0047-8
P577
2013-02-01T00:00:00Z